1. Signaling Pathways
  2. GPCR/G Protein
  3. Protease Activated Receptor (PAR)
  4. Protease Activated Receptor (PAR) Agonist

Protease Activated Receptor (PAR) Agonist

Protease Activated Receptor (PAR) Agonists (37):

Cat. No. Product Name Effect Purity
  • HY-P0226
    TFLLR-NH2
    Agonist
    TFLLR-NH2 is a selective PAR1 agonist with an EC50 of 1.9 μM.
  • HY-120528
    GB-110
    Agonist
    GB-110 is a potent, orally active, and nonpeptidic protease activated receptor 2 (PAR2) agonist. GB-110 selectively induces PAR2-mediated intracellular Ca2+ release in HT29 cells with an EC50 of 0.28 μM.
  • HY-138951
    AY77
    Agonist
    AY77 is a calcium-biased PAR2 agonist. AY77 shows an EC50 of 0.17 and 2 nM in PAR2-mediated the activation in the Gq pathway and recruitment of β-arrestin-2, respectively. AY77 potently induces intracellular Ca2+ release.
  • HY-P4451
    TRAP-5 amide
    Agonist
    TRAP-5 amide is a protease-activated receptor 1 (PAR 1) agonist peptide.
  • HY-P2519
    Protease-Activated Receptor-3 (PAR-3) (1-6), human
    Agonist
    Protease-Activated Receptor-3 (PAR-3) (1-6), human is a proteinase-activated receptor (PAR-3) agonist peptide.
  • HY-P1262A
    Parstatin(human) TFA
    Agonist
    Parstatin(human) TFA, a cell-penetrating PAR-1 thrombin receptor agonist peptide, is a potent inhibitor of angiogenesis.
  • HY-P1313A
    PAR 4 (1-6) (TFA)
    Agonist
    PAR 4 (1-6) TFA (GYPGQV TFA), a hexapeptide, is a fragment of protease-activated receptor 4 (PAR4). PAR 4 (1-6) TFA acts as a PAR4-specific agonist.
  • HY-P1261
    Parstatin(mouse)
    Agonist
    Parstatin(mouse), a cell-penetrating PAR-1 thrombin receptor agonist peptide, is a potent inhibitor of angiogenesis.
  • HY-P5372
    Ala-parafluoroPhe-Arg-Cha-Cit-Tyr-NH2
    Agonist
    Ala-parafluoroPhe-Arg-Cha-Cit-Tyr-NH2 is a biological active peptide. (Protease activated receptor 1 (PAR-1) belongs to a subfamily of G-protein coupled receptors and is known to mediate the cellular effects of thrombin. This peptide is a PAR-1 selective agonist displaying a high level of specificity to PAR-1 over PAR-2. The specificity of peptide was evaluated in cell-based calcium signaling assay using HEK293 cells. PAR-1 selective agonists can be used to study PAR-1 activation in vivo. In addition to its varied cellular effects of thrombin, PAR-1 has also been shown to coordinate with PAR-4 and regulate thrombin-induced hepatocellular carcinoma harboring thrombin formation within the tumor environment classified as 'coagulation type'.)
  • HY-P3259
    AY254
    Agonist
    AY254 is an analogue of AY77 (HY-138951). AY254 is ERK-biased PAR2 agonist with an EC50 of 2 nM. AY254 relieves cytokine-induced caspase 3/8 activation. AY254 also promotes scratch-wound healing and induced IL-8 secretion via PAR2-ERK1/2 signaling
  • HY-P1314A
    2-Furoyl-LIGRLO-amide TFA
    Agonist
    2-Furoyl-LIGRLO-amide TFA is a potent and selective proteinase-activated receptor 2 (PAR2) agonist with a pD2 value of 7.0..
  • HY-P1310A
    VKGILS-NH2 TFA
    Agonist
    VKGILS-NH2 TFA is a reversed amino acid sequence control peptide for SLIGKV-NH2 (protease-activated receptor 2 (PAR2) agonist). VKGILS-NH2 TFA has no effect on DNA synthesis in cells.
  • HY-P5358
    YFLLRNP
    Agonist
    YFLLRNP is a biological active peptide. (a partial agonist of PAR-1. YFLLRNP selectively active G12/13 signaling pathway without activating Gq or Gi pathways at low concentrations. YFLLRNP (60 μM))
  • HY-P1262
    Parstatin(human)
    Agonist
    Parstatin(human), a cell-penetrating PAR-1 thrombin receptor agonist peptide, is a potent inhibitor of angiogenesis.
  • HY-P1313
    PAR 4 (1-6) (human)
    Agonist
    PAR 4 (1-6) human, a hexapeptide, is a fragment of protease-activated receptor 4 (PAR4). PAR 4 (1-6) TFA acts as a PAR4-specific agonist.
  • HY-P2321A
    TRAP-6 amide TFA
    Agonist
    TRAP-6 amide TFA is a PAR-1 thrombin receptor agonist peptide.
  • HY-P1308A
    SLIGRL-NH2 TFA
    Agonist
    SLIGRL-NH2 TFA (Protease-Activated Receptor-2 Activating Peptide TFA) is an agonist of Protease-Activated Receptor-2 (PAR-2).